Swiss drug major Novartis' Indian arm is upbeat about its rural sales initiative, Arogya Parviar and plans to double its reach in the country over the next few years. "Arogya Parivar that started......
India’s intent to respect intellectual property may have drawn international criticism following the Supreme Court’s decision on Glivec, but facts point at a different story.After Swiss......
Novartis, the fourth largest pharmaceutical company in the world, has zeroed in on Hyderabad for setting up its healthcare-related IT/ITES and R&D facility.A memorandum of understanding in this......
Sandoz, the generic arm of Swiss drug maker Novartis, has decided to shut its facility for development of generic drugs in India. The facility, known as Sandoz Development Centre located near......
Sandoz, the generic arm of Swiss drug maker Novartis, recently closed its facility developing active pharmaceutical ingredients (API) near Mumbai, a person close to the development told Business......